Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/06/2003CN1434719A Preparation capable of mobilization of activity
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434707A Method and compositions for preventing hormone induced adverse effects
08/06/2003CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434703A Delayed release compositions and combinations
08/06/2003CN1434701A Y-IFN liquid-droplet aerosol and method
08/06/2003CN1434681A Method for maintaining on improving the synthesis of mucins
08/06/2003CN1434121A Fermentation production technology for olry bacterial powder containing gama-linolenic acid
08/06/2003CN1434055A Platelet glucoprotein receptor inhibitor, medicinal composition containing same and use thereof
08/06/2003CN1433811A Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy
08/06/2003CN1117510C Method and system for controlling connections to mobile station in cellular telecommunications system
08/06/2003CN1117155C Novel compounds
08/06/2003CN1117154C Urokinase zymogen mutant
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
08/06/2003CN1116897C Parathyroid hormone medicine coposition
08/06/2003CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6602993 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases
08/05/2003US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen
08/05/2003US6602985 Extraction of zein protein from gluten meal
08/05/2003US6602984 Human elastase IV
08/05/2003US6602982 Process for the preparation of regular glycopeptides
08/05/2003US6602981 Antinociceptive agent derivative
08/05/2003US6602979 Screening assays for compounds that cause apoptosis
08/05/2003US6602978 Polypeptide, of given amino acid sequence, specific for binding to a receptor; antibodies against the peptides are useful for enhancing or inhibiting inflammation and early effects of wound healing
08/05/2003US6602975 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
08/05/2003US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers
08/05/2003US6602857 Antisense modulation of PTP1B expression
08/05/2003US6602856 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602853 Antigenic peptides reacting with anti-ovary antibodies
08/05/2003US6602850 Method of treating asthma using soluble IL-9 receptor variants
08/05/2003US6602849 Cyclic somatostatin analogs
08/05/2003US6602713 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
08/05/2003US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602698 Human kinase proteins and polynucleotides encoding the same
08/05/2003US6602693 Gene encoding hyaluronan synthase
08/05/2003US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602674 Uses of antileukoprotease in carcinoma
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602526 Anti-aging component containing methyltransferase and a carrier
08/05/2003US6602519 Peptide factor used as replacement to steroid therapy; neutrophil migration stimulating activity; treating conditions associated with an inflammatory response of septic shock
08/05/2003US6602510 Eight isolated epitopes YLSGANLNV (SEQ ID NO:1), IMIGVLVGV (SEQ ID NO:2), KLBPVQLWV (SEQ ID NO:3), SMPPPGTRV (SEQ ID NO:4), KVAELVHFL (SEQ ID NO:5), YLQLVFGIEV (SEQ ID NO:6), RLLQETELV (SEQ ID NO:7), and, VVLGVVFGI (SEQ ID NO:8).
08/05/2003US6602509 Compound and method for the prevention and/or the treatment of allergy
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602504 Useful in prophylaxis, therapy, and diagnosis of infections in canines
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602502 Improved immunoassays of psychotomimetic drugs, narcotic drugs, tetrahydrocannabinols; use of the haptenic properties of psychoactive material; blood test N,N-Dimethyltryptamine and 5-Methoxy-N,N- Dimethyltryptamine
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003US6602294 Implantable substrates for the healing and protection of connecting tissue, preferably cartilage
08/05/2003CA2329259C Convection-enhanced delivery of aav vectors
08/05/2003CA2115943C Novel process for the preparation of cetrorelix lyophilisate
08/05/2003CA1341436C Synthetic antigens for the detection of aids-related disease caused by lav-2
08/01/2003CA2370396A1 Hepatitis c inhibitor tri-peptides
08/01/2003CA2369970A1 Hepatitis c inhibitor tri-peptides
07/2003
07/31/2003WO2003062832A1 Fertility screening method and kit
07/31/2003WO2003062830A2 Fibronectin variants and screening methods
07/31/2003WO2003062788A2 Method for inhibiting angiogenesis
07/31/2003WO2003062472A1 Cooperative oligonucleotides
07/31/2003WO2003062467A2 Tissue rejection
07/31/2003WO2003062448A2 Sqv nucleic acids and polypeptides
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062432A1 Method for increasing the efficiency of an inhibitor of tyrosine kinase activity
07/31/2003WO2003062431A2 Production of epi-hne-4 comprising reduction of improperly processed form
07/31/2003WO2003062423A2 Method for inhibiting the expression of a target gene resulting from a chromosome aberration
07/31/2003WO2003062421A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
07/31/2003WO2003062420A1 Molecular libraries
07/31/2003WO2003062413A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
07/31/2003WO2003062410A2 Torero protein
07/31/2003WO2003062401A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
07/31/2003WO2003062394A2 Methods and compositions for rna interference
07/31/2003WO2003062392A2 Methods of treating conditions associated with an edg receptor
07/31/2003WO2003062391A2 Structural and cytoskeleton-associated proteins
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062386A2 Syndecans and angiogenesis
07/31/2003WO2003062373A2 Methods and materials for the recruitment of endothelial cells
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062277A1 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062273A2 Modulator of the notch signalling pathway and use thereof in medical treatment
07/31/2003WO2003062272A1 Novel strategy for modulating t cell activation which is based on regulating the cd3ε - nck interaction
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062269A2 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062268A2 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062265A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003062261A2 Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
07/31/2003WO2003062258A1 Rnase l activator-antisense complexes
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062197A2 Nek2 inhibitors
1 ... 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 ... 3163